<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Peters | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/harpafrica65/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/harpafrica65/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Peters.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">9b1ac4b5dd03c5d9154c2e4f5ab3e016</guid>
				<title>Peters posted an update: The as-synthesized DOX/PEI@TeNP system can produce reactive [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42397/</link>
				<pubDate>Sun, 09 Feb 2025 09:10:04 -0800</pubDate>

									<content:encoded><![CDATA[<p>The as-synthesized DOX/PEI@TeNP system can produce reactive oxygen species (ROS) under near-infrared (NIR) light irradiation and features a high photothermal conversion efficiency due to its strong NIR absorbance. Therefore, this study provides an effective strategy for the effective design of nano-drugs, which can be used for the accurate&hellip;<span class="activity-read-more" id="activity-read-more-42397"><a href="http://www.nationalboardinstitute.com/activity/p/42397/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a477c22002ab3033c9539f94ecb7819b</guid>
				<title>Peters posted an update: 001 and p = 0.004). Contraction strength explained, at mos [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40809/</link>
				<pubDate>Fri, 07 Feb 2025 09:21:42 -0800</pubDate>

									<content:encoded><![CDATA[<p>001 and p = 0.004). Contraction strength explained, at most, 4% of UGH (r = 0.17) or LH (r = 0.20) shortening during contraction (r = 0.17 and r = 0.20, respectively), indicating that these factors are largely independent. After controlling for prolapse size, resting UGH and levator defect status were associated with straining UGH (p &lt; 0.001,&hellip;<span class="activity-read-more" id="activity-read-more-40809"><a href="http://www.nationalboardinstitute.com/activity/p/40809/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">451de7807b8f024cedb1c42dfac61e74</guid>
				<title>Peters posted an update: Knockdown of Piezo2 in NG also attenuated the baroreflex and [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/39627/</link>
				<pubDate>Thu, 06 Feb 2025 09:13:27 -0800</pubDate>

									<content:encoded><![CDATA[<p>Knockdown of Piezo2 in NG also attenuated the baroreflex and increased serum norepinephrine (NE) concentration in WKY rats. Co-immunoprecipitation experiment suggested that Piezo2 interacted with Neural precursor cell-expressed developmentally downregulated gene 4 type 2 (Nedd4-2, also known as Nedd4L); Electrophysiological results showed that&hellip;<span class="activity-read-more" id="activity-read-more-39627"><a href="http://www.nationalboardinstitute.com/activity/p/39627/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">45149b82fc1c60a439cd281aa2419586</guid>
				<title>Peters posted an update: ute to the diagnosis, treatment and follow-up of diabetic [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/38885/</link>
				<pubDate>Wed, 05 Feb 2025 09:04:14 -0800</pubDate>

									<content:encoded><![CDATA[<p>ute to the diagnosis, treatment and follow-up of diabetic nephropathy in the future.</p>
<p> The Environmental Determinants of Diabetes in the Young (TEDDY) is a prospective birth cohort designed to study type 1 diabetes (T1D) by following children with high genetic risk. An integrative multi-omics approach was used to evaluate islet autoimmunity&hellip;<span class="activity-read-more" id="activity-read-more-38885"><a href="http://www.nationalboardinstitute.com/activity/p/38885/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">49f7e04252d6c01aa1811ecdbf5c02ba</guid>
				<title>Peters posted an update: The evidence that oxidation and inactivation of OGs and CDs [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/38058/</link>
				<pubDate>Tue, 04 Feb 2025 09:11:55 -0800</pubDate>

									<content:encoded><![CDATA[<p>The evidence that oxidation and inactivation of OGs and CDs may be a general strategy of plants for controlling the homeostasis of DAMPs is discussed. The possibility exists of discovering additional oxidative and/or inactivating enzymes targeting other DAMP molecules both in the plant and in animal kingdoms.Raffinose family oligosaccharides&hellip;<span class="activity-read-more" id="activity-read-more-38058"><a href="http://www.nationalboardinstitute.com/activity/p/38058/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">10dcdfe06a5020b7208edf33c2f5bbd7</guid>
				<title>Peters posted an update: Patients suffering from malignant diseases receive very [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/37214/</link>
				<pubDate>Mon, 03 Feb 2025 09:31:54 -0800</pubDate>

									<content:encoded><![CDATA[<p>Patients suffering from malignant diseases receive very often highly emetogenic chemotherapy as part of their treatment. With the aim of assessing the efficacy of cannabinoids in treating chemotherapy-induced nausea and vomiting (CINV), we searched the literature published until April 2020 in Medline/PubMed, Embase, the Cochrane Controlled Trials&hellip;<span class="activity-read-more" id="activity-read-more-37214"><a href="http://www.nationalboardinstitute.com/activity/p/37214/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9d82b10b000e85b6ab192ac803484941</guid>
				<title>Peters posted an update: 38, 95% CI 0.15-0.98, p=0.047) and OS (HR 0.37, 95% CI [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/36219/</link>
				<pubDate>Sun, 02 Feb 2025 09:03:38 -0800</pubDate>

									<content:encoded><![CDATA[<p>38, 95% CI 0.15-0.98, p=0.047) and OS (HR 0.37, 95% CI 0.13-0.99, p=0.047). In subgroup analysis, the CR after CCRT followed by ACT group showed significantly higher locoregional recurrence-free survival (p=0.02), OS (p=0.003), distant-metastasis free survival (p=0.07), and PFS (p=0.01) than the other three groups.</p>
<p> Tumor regression 1month&hellip;<span class="activity-read-more" id="activity-read-more-36219"><a href="http://www.nationalboardinstitute.com/activity/p/36219/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">aba71ca56fcbc384f987d4d970a7d73a</guid>
				<title>Peters posted an update: 3 (IQR 1.8-13.1) years. Using GSRS, 88% of participants [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/35258/</link>
				<pubDate>Sat, 01 Feb 2025 08:49:26 -0800</pubDate>

									<content:encoded><![CDATA[<p>3 (IQR 1.8-13.1) years. Using GSRS, 88% of participants reported at least 1 gastrointestinal symptom, most commonly indigestion (57%) and diarrhea (54%). Using GIQLI, 42% and 38% of participants reported mild and moderate QOL impairment, respectively. Gastrointestinal symptoms were predicted by female sex (coefficient-0.11, 95% CI-0.21 to-0.02)&hellip;<span class="activity-read-more" id="activity-read-more-35258"><a href="http://www.nationalboardinstitute.com/activity/p/35258/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a7f3faad60f55c6cacae8693595a5637</guid>
				<title>Peters posted an update: 0%) had significantly higher DAS28-CRP (3.6 vs 3.0), HAQ-DI [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/34414/</link>
				<pubDate>Fri, 31 Jan 2025 08:45:15 -0800</pubDate>

									<content:encoded><![CDATA[<p>0%) had significantly higher DAS28-CRP (3.6 vs 3.0), HAQ-DI (0.50 vs 0.12), and mTSS (21 vs 7) than young RA patients without myopenia (n = 280, 43.5%; all p less then 0.0083). Multivariate logistic and linear regression analyses showed that myopenia, high HAQ-DI, active smoking, hypertension, diabetes, and coronary atherosclerotic heart disease&hellip;<span class="activity-read-more" id="activity-read-more-34414"><a href="http://www.nationalboardinstitute.com/activity/p/34414/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">13f9726edda4691fedfe5af05e43eea4</guid>
				<title>Peters posted an update: The association between a history of hypertensive disorders [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/32932/</link>
				<pubDate>Wed, 29 Jan 2025 09:16:30 -0800</pubDate>

									<content:encoded><![CDATA[<p>The association between a history of hypertensive disorders of pregnancy (HDP) and subsequent type 2 diabetes (referred to throughout as diabetes) remains inconclusive. We reviewed the most recent evidence to quantify the association of previous HDP with incident diabetes.</p>
<p> A systematic search of MEDLINE, Embase and CINAHL was performed up&hellip;<span class="activity-read-more" id="activity-read-more-32932"><a href="http://www.nationalboardinstitute.com/activity/p/32932/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">da9ee451b7e5fac013f4127ab480e899</guid>
				<title>Peters posted an update: The transboundary Tigris-Euphrates Basin (TEB) is prone to [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/27370/</link>
				<pubDate>Tue, 28 Jan 2025 09:05:18 -0800</pubDate>

									<content:encoded><![CDATA[<p>The transboundary Tigris-Euphrates Basin (TEB) is prone to water-scarcity disputes. Water scarcity is related to aridity, climate extremes, limited supplies, upstream reservoir storage, rising water demand, and population growth. Understanding the water budget and storage changes in the basin in relation to hydrological extremes is fundamental to&hellip;<span class="activity-read-more" id="activity-read-more-27370"><a href="http://www.nationalboardinstitute.com/activity/p/27370/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">740c264b2127dea67d196ff43a967840</guid>
				<title>Peters became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/27314/</link>
				<pubDate>Tue, 28 Jan 2025 08:59:18 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>